Literature DB >> 25757021

Institutional adherence to cardiovascular risk factor screening guidelines for young survivors of acute lymphoblastic leukemia.

Maria H Lin1, Jamie R Wood, Steven D Mittelman, David R Freyer.   

Abstract

Survivors of acute lymphoblastic leukemia have increased risk for long-term cardiovascular complications. Early identification of cardiovascular risk factors (CVRF) may allow for effective interventions. In this retrospective cohort study of 194 patients at Children's Hospital Los Angeles, we investigated CVRF screening practices in an established childhood cancer survivorship program relative to both the Children's Oncology Group (COG) Long-Term Follow-Up Guidelines and American Academy of Pediatrics (AAP) recommendations. CVRF screening practices met COG but not the more stringent AAP recommendations, particularly in areas of dyslipidemia and diabetes screening. Implications of our findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25757021     DOI: 10.1097/MPH.0000000000000320

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Obesity and Risk for Second Malignant Neoplasms in Childhood Cancer Survivors: A Case-Control Study Utilizing the California Cancer Registry.

Authors:  Diana J Moke; Ann S Hamilton; Leena Chehab; Dennis Deapen; David R Freyer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07-23       Impact factor: 4.254

2.  Trends in Influenza Vaccine Uptake and Severe Influenza-Related Outcomes at Kaiser Permanente Southern California, 2007-2017.

Authors:  In-Lu Amy Liu; Hilary C Tanenbaum; Lei Qian; Lina S Sy; Wansu Chen; Steven J Jacobsen
Journal:  Perm J       Date:  2021-05

3.  Cardiometabolic Risk Factors in Childhood, Adolescent and Young Adult Survivors of Acute Lymphoblastic Leukemia - A Petale Cohort.

Authors:  Emile Levy; Mariia Samoilenko; Sophia Morel; Jade England; Devendra Amre; Laurence Bertout; Simon Drouin; Caroline Laverdière; Maja Krajinovic; Daniel Sinnett; Geneviève Lefebvre; Valérie Marcil
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.